Your session is about to expire
← Back to Search
Not Applicable
Mobile Health Intervention for Young Adult Cancer Survivors (mHealthAYA Trial)
N/A
Recruiting
Led By Carla J Berg, PhD
Research Sponsored by George Washington University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months (end-of-treatment; eot) and 6-month (follow-up; fu)
Awards & highlights
mHealthAYA Trial Summary
This trial aims to test an 8-week phone & app intervention to promote hope & mitigate life disruption caused by cancer in young adults. It involves formative research & an RCT of the intervention vs. attention control in 150 YA survivors. High impact due to reach & scalability.
Who is the study for?
This trial is for young adults aged 20-39 who have been treated for stages I-IV cancer within the last three years. Participants should not have significant psychological disabilities, must understand English, and need to have a smartphone. They also must be willing to commit to an 8-week study that's delivered remotely.Check my eligibility
What is being tested?
The trial is testing an 8-week phone and app-based intervention designed to boost hope and improve quality of life after cancer treatment. It involves comparing this new method with a control group in a randomized controlled trial among 150 young adult survivors.See study design
What are the potential side effects?
Since the intervention focuses on mental health support through technology, there are no direct medical side effects like you'd expect from medication or surgery. However, participants may experience emotional or psychological responses as they engage with the content.
mHealthAYA Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months (end-of-treatment; eot) and 6-month (follow-up; fu)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months (end-of-treatment; eot) and 6-month (follow-up; fu)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability
Adherence
Retention
Secondary outcome measures
Alcohol use
Cannabis use
Hope, per Snyder's Hope Scale
+5 moremHealthAYA Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The intervention utilizes an empirically supported protocol, further refined with evidence-based strategies targeting the needs of young adult (YA) survivors. Its long-term goal is to promote hopeful thinking, and ultimately enhance other long-term markers of quality of life (QOL) (including mental health and health behaviors). The intervention follows 8 weekly curricula, reinforced through psychoeducation and skill-building, homework/practical application, and self-monitoring. Its 8-week design was informed by cognitive behavioral therapy and positive psychology intervention literature.
Group II: Attention ControlActive Control1 Intervention
Health education regarding maintaining a healthy weight, physical activity, and nutrition, based on American Cancer Society and NCI guidelines/recommendations.
Find a Location
Who is running the clinical trial?
George Washington UniversityLead Sponsor
243 Previous Clinical Trials
453,047 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,736 Previous Clinical Trials
40,967,443 Total Patients Enrolled
Carla J Berg, PhDPrincipal InvestigatorGeorge Washington University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I was diagnosed with cancer between the ages of 20 and 39.I finished my cancer treatment aimed at curing it within the last three years.I finished my cancer treatment over three years ago or am currently in treatment.I can participate in an 8-week study from home.
Research Study Groups:
This trial has the following groups:- Group 1: Attention Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger